Stryker Corporation (SYK) was Initiated by Guggenheim to “Buy”. Guggenheim advised their investors in a research report released on Jun 9, 2016.
Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Stryker Corporation closed down -0.94 points or -0.83% at $112.59 with 14,07,360 shares getting traded on Tuesday. Post opening the session at $113.53, the shares hit an intraday low of $112.57 and an intraday high of $113.5999 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
Investors should note that on Apr 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Jun 28, 2016 as the ex-dividend date and fixed the record date on Jun 30, 2016. The payable date has been fixed on Jul 29, 2016.
In a different news, on Jun 8, 2016, Srikant Datar (director) sold 6,565 shares at $113.90 per share price. According to the SEC, on Jun 7, 2016, Ronda E Stryker (director) sold 12,000 shares at $113.47 per share price. On Jun 2, 2016, Timothy J Scannell (Group President) sold 9,945 shares at $110.72 per share price, according to the Form-4 filing with the securities and exchange commission.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.